Gary Middleton

Trials

Studies that name Gary Middleton as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 20:35 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT03981146 · A Phase II Trial Assessing Nivolumab in Class II Expressing Microsatellite Stable Colorectal Cancer

  University of Birmingham · completed · Colorectal Cancer · principal investigator
• Ph1
  NCT03371485 · AST-VAC2 Vaccine in Patients With Non-small Cell Lung Cancer

  Cancer Research UK · completed · Advanced Non-small Cell Lung Cancer · principal investigator
• Ph2
  NCT02733159 · Pembrolizumab in Patients With Non-Small Cell Lung Cancer and a Performance Status 2

  University of Birmingham · completed · Carcinoma, Non-Small-Cell Lung · principal investigator
• Ph2
  NCT01601808 · Clinical Trial Comparing Gemcitabine and Vandetanib Therapy With Gemcitabine Alone in Pancreatic Carcinoma

  University of Liverpool · completed · Pancreatic Cancer · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-11 20:35 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.